Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{171113,
author = {Miss Vaishnavi D. Ingle and Dr. Shivshankar D. Mhaske and Prof. Vikas K. Gawande and Prof. Pankaj P. Fitwe},
title = {Agastya Haritaki: A Comprehensive Review of its Immunomodulatory and Therapeutic Potential in Ayurveda},
journal = {International Journal of Innovative Research in Technology},
year = {2024},
volume = {11},
number = {7},
pages = {2511-2521},
issn = {2349-6002},
url = {https://ijirt.org/article?manuscript=171113},
abstract = {Agastya Haritaki is a drug mentioned in the Rasayoga, a text in Ayurveda compiled before 1649. Agastya Haritaki has been claimed as the readings of three different texts, which represent it biomedically, thus making it a drug of scientific importance. Agastya Haritaki can be correlated with Shorea robusta and Terminalia chebula in combination, which are Rasayana drugs. Although many Ayurvedic classics mention these two ingredients in their formulations, in Agastya Haritaki, they are written as the main drugs that can improve the retentive power of the gut in addition to their anti-aging properties. These two medications have been popular for a very long time among the Indian population, which supports their potential adverse effects and drug interaction possibilities as claimed by Ayurveda.
The literature on scientific research on Agastya Haritaki includes only two peer-reviewed publications and seven abstracts. Based on the preclinical and clinical studies, it can be concluded that immunomodulation may be the major mode of action of Agastya Haritaki. The assertion is due to the only major formulation that includes Triphala, which is nowadays the most commonly used immunomodulatory medication, an excellent antioxidant, and a very good adaptogen. It acts as an immune stimulant when consumed in lower doses and as an immunosuppressant in higher doses. It also contains powdered gold, indicating the presence of an immunomodulatory element at that time, which is now proven and described as gold attached to an active molecule, utilizing biotechnology. The possibility of the hidden active component of Agastya Haritaki and the major formulation including this medication in the management of current human health problems has also been reviewed in the present publication.},
keywords = {Ayurveda in disease cure, Agastya haritaki},
month = {December},
}
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry